Viewing Study NCT05403333


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2026-01-12 @ 3:24 AM
Study NCT ID: NCT05403333
Status: UNKNOWN
Last Update Posted: 2022-06-03
First Post: 2022-04-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer
Sponsor: Fudan University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-06-10
Start Date Type: ESTIMATED
Primary Completion Date: 2023-03-09
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-03-09
Completion Date Type: ESTIMATED
First Submit Date: 2022-04-18
First Submit QC Date: None
Study First Post Date: 2022-06-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-05-30
Last Update Post Date: 2022-06-03
Last Update Post Date Type: ACTUAL